Skip to main content

Animations

MJFF Publications

171 - 180 of 8587 Results
Title
Year
  • Year
  • 2020
  • 2015
  • 2020
  • 2021
  • 2021
  • 2021
  • 2022
  • 2022
  • 2020
  • 2020
  • Summary Details
    RESTRICTED
    Title: At the dawn of the transcriptomic medicine
    Journal Name: Experimental Biology and Medicine
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1177/1535370220954788
    Citation Count: 7
  • Summary Details
    RESTRICTED
    Title: Transcriptional mutagenesis by 8-oxodG in α-synuclein aggregation and the pathogenesis of Parkinson’s disease
    Journal Name: Experimental & Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/emm.2015.54
    Citation Count: 27
  • Summary Details
    RESTRICTED
    Title: Mitochondrial isolation: when size matters
    Journal Name: Wellcome Open Research
    Publisher: F1000 Research Ltd
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.12688/wellcomeopenres.16300.2
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: Intracellular Thermometry at the Micro‐/Nanoscale and its Potential Application to Study Protein Aggregation Related to Neurodegenerative Diseases
    Journal Name: ChemBioChem
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/cbic.202000765
    Best OA location URL:
    Citation Count: 9
  • Summary Details
    RESTRICTED
    Title: Recent Advances in the Development of Stem‐Cell‐Derived Dopaminergic Neuronal Transplant Therapies for Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28628
    Best OA location URL:
    Citation Count: 34
  • Summary Details
    RESTRICTED
    Title: Synaptic tau: A pathological or physiological phenomenon?
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-021-01246-y
    Citation Count: 39
  • Summary Details
    RESTRICTED
    Title: How to proceed after “negative” exome: A review on genetic diagnostics, limitations, challenges, and emerging new multiomics techniques
    Journal Name: Journal of Inherited Metabolic Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/jimd.12507
    Citation Count: 20
  • Summary Details
    RESTRICTED
    Title: GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awac413
    Citation Count: 11
  • Summary Details
    RESTRICTED
    Title: Risk of Chronic Cardiomyopathy Among Patients With the Acute Phase or Indeterminate Form of Chagas Disease
    Journal Name: JAMA Network Open
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1001/jamanetworkopen.2020.15072
    Citation Count: 50
  • Summary Details
    RESTRICTED
    Title: LRRK2 Phosphorylation, More Than an Epiphenomenon
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2020.00527
    Citation Count: 41
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.